Compare Lustrum:Nxera Pharma Co., Ltd.:4565

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Nxera Pharma Co., Ltd. Go to web site 4565 Medicals 東証プライム December 1, 2000 2004.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Nxera Pharma Co., Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Nxera Pharma Co., Ltd. Balance Sheet 2023年12月期 Nxera Pharma Co., Ltd. Balance Sheet 2022年12月期 Nxera Pharma Co., Ltd. Balance Sheet 2021年12月期 Nxera Pharma Co., Ltd. Balance Sheet 2020年12月期 Nxera Pharma Co., Ltd. Balance Sheet 2019年12月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Cash and Cash Equivalents
(Percent)
49,065down
(31.2%)down
66,557up
(66.9%)up
60,087up
(62.0%)up
40,008up
(52.3%)up
15,375
(27.1%)
Other Current AssetsHelp
(Percent)
16,047up
(10.2%)up
3,385up
(3.4%)up
2,721up
(2.8%)up
2,010down
(2.6%)down
4,188
(7.4%)
Tangible Fixed AssetsHelp
(Percent)
7,900up
(5.0%)up
3,791down
(3.8%)down
3,817down
(3.9%)down
3,824down
(5.0%)down
4,120
(7.3%)
Intangible Fixed AssetHelp
(Percent)
52,291up
(33.3%)up
8,577down
(8.6%)down
9,120down
(9.4%)down
11,802down
(15.4%)down
12,999
(22.9%)
Investments and OthersHelp
(Percent)
7,272up
(4.6%)up
1,801down
(1.8%)down
6,145up
(6.3%)up
4,687down
(6.1%)down
5,633
(9.9%)
Total AssetsHelp
(Percent)
157,198
(100%)
99,417
(100%)
96,985
(100%)
76,465
(100%)
56,680
(100%)
Total Current LiabilitiesHelp
(Percent)
23,188up
(14.8%)up
11,923up
(12.0%)up
10,439up
(10.8%)up
7,631down
(10.0%)down
8,412
(14.8%)
Total Long-term LiabilitiesHelp
(Percent)
67,200up
(42.7%)up
29,558up
(29.7%)down
29,078up
(30.0%)up
16,453up
(21.5%)up
3,193
(5.6%)
Shareholder's EquityHelp
(Percent)
66,810up
(42.5%)down
57,936up
(58.3%)down
57,468up
(59.3%)down
52,381up
(68.5%)down
45,075
(79.5%)
Total LiabilitiesHelp
(Percent)
157,198
(100%)
99,417
(100%)
96,985
(100%)
76,465
(100%)
56,680
(100%)

Nxera Pharma Co., Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Nxera Pharma Co., Ltd. Profit and Loss Account 2023年12月期 Nxera Pharma Co., Ltd. Profit and Loss Account 2022年12月期 Nxera Pharma Co., Ltd. Profit and Loss Account 2021年12月期 Nxera Pharma Co., Ltd. Profit and Loss Account 2020年12月期 Nxera Pharma Co., Ltd. Profit and Loss Account 2019年12月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Amount of Sales
(Percent)
12,766
(100%)
15,569
(100%)
17,712
(100%)
8,842
(100%)
9,726
(100%)
Total Sales
(Percent)
12,766
(100%)
15,569
(100%)
17,712
(100%)
8,842
(100%)
9,726
(100%)
Cost of SalesHelp
(Percent)
3,102up
(24.3%)up
926down
(5.9%)up
933up
(5.3%)down
761
(8.6%)up
761
(7.8%)
Other Costs and RevenueHelp 16,857up
(132.0%)up
14,261down
(91.6%)up
15,762up
(89.0%)up
6,602down
(74.7%)down
7,533
(77.5%)
Total CostsHelp 19,959 15,187 16,695 7,363 8,294
Net RevenueHelp 9,664down
(75.7%)down
14,643down
(94.1%)down
16,779up
(94.7%)up
8,081down
(91.4%)down
8,965
(92.2%)
Earnings Before TaxHelp -10,680down
(-83.7%)down
1,078up
(6.9%)up
433down
(2.4%)down
1,622up
(18.3%)up
534
(5.5%)
Net IncomeHelp -7,193down
(-56.3%)down
382down
(2.5%)down
1,017down
(5.7%)down
1,479up
(16.7%)up
1,432
(14.7%)
当期純利益 -7,193 382 1,017 1,479 1,432

Nxera Pharma Co., Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Nxera Pharma Co., Ltd. Cash Flow Statement 2023年12月期 Nxera Pharma Co., Ltd. Cash Flow Statement 2022年12月期 Nxera Pharma Co., Ltd. Cash Flow Statement 2021年12月期 Nxera Pharma Co., Ltd. Cash Flow Statement 2020年12月期 Nxera Pharma Co., Ltd. Cash Flow Statement 2019年12月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Operating Cash Flow(OFC)Help
(Percent)
-5,273down
(-7.6%)down
9,952up
(87.6%)up
7,095up
(35.3%)up
4,672up
(18.7%)down
3,441
(47.7%)
Investing Cash Flow(ICF)Help
(Percent)
-63,791down
(-92.4%)down
1,043up
(9.2%)up
278up
(1.4%)up
-150up
(-0.6%)up
-246
(-3.4%)
Financing Cash FlowHelp
(Percent)
48,329up
(70.0%)up
-4,887down
(-43.0%)down
11,123down
(55.4%)down
20,278up
(81.3%)up
-6,964
(-96.6%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
3,243up
(4.7%)up
362down
(3.2%)down
1,583up
(7.9%)up
-167down
(-0.7%)down
384
(5.3%)
Net Increase and Decrease in Cash and Cash Equivalentsn -17,492down
(-25.3%)down
6,470down
(57.0%)down
20,079down
(100.0%)up
24,633up
(98.7%)up
-3,385
(-46.9%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Nxera Pharma Co., Ltd.

Company where related level is highHelp

Toyama Chemical Co.,Ltd.
Kringle Pharma,Inc.
SAWAI GROUP HOLDINGS Co., Ltd.
AnGes,Inc.
RaQualia Pharma Inc.
CellSource Co., Ltd.
ZERIA PHARMACEUTICAL CO.,LTD.
Chiome Bioscience Inc.
R-TECH UENO,LTD.
Mitsubishi Tanabe Pharma Corporation